Ranibizumab

RAHWAY, N.J. — September 24, 2026 Merck announced topline results from the pivotal Phase 2b/3 BRUNELLO study evaluating remigromig...

Basel, Switzerland, September 21, 2026 Roche has announced that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL) for...

BASEL, Switzerland, July 24, 2026 Roche announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use...

INCHEON, South Korea & NASHVILLE, Tenn., July 20, 2026 Samsung Bioepis Co., Ltd. and Harrow, Inc. have presented positive...

NASHVILLE, Tenn., July 20, 2026 Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America,...

Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...

STOCKHOLM, Sweden, June 3, 2026 Xbrane Biopharma AB has reached a significant regulatory milestone after the U.S. Food and...